• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病与 SARS-CoV-2 进入受体 ACE2 血浆水平的共享遗传和因果关联。

Shared genetics and causal association between plasma levels of SARS-CoV-2 entry receptor ACE2 and Alzheimer's disease.

机构信息

Department of Pathology, The Affiliated Hospital of Weifang Medical University, Weifang, China.

Department of Neurology, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China.

出版信息

CNS Neurosci Ther. 2024 Jul;30(7):e14873. doi: 10.1111/cns.14873.

DOI:10.1111/cns.14873
PMID:39056224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273102/
Abstract

BACKGROUND

Alzheimer's disease (AD) is the highest risk of COVID-19 infection, hospitalization, and mortality. However, it remains largely unclear about the link between AD and COVID-19 outcomes. ACE2 is an entry receptor for SARS-CoV-2. Circulating ACE2 is a novel biomarker of death and associated with COVID-19 outcomes.

METHODS

Here, we explored the shared genetics and causal association between AD and plasma ACE2 levels using large-scale genome-wide association study, gene expression, expression quantitative trait loci, and high-throughput plasma proteomic profiling datasets.

RESULTS

We found a significant causal effect of genetically increased circulating ACE2 on increased risk of AD. Cross-trait association analysis identified 19 shared genetic variants, and three variants rs3104412, rs2395166, and rs3135344 at chromosome 6p21.32 were associated with COVID-19 infection, hospitalization, and severity. We mapped 19 variants to 117 genes, which were significantly upregulated in lung, spleen, and small intestine, downregulated in brain tissues, and involved in immune system, immune disease, and infectious disease pathways. The plasma proteins corresponding to LST1, AGER, TNXB, and APOC1 were predominantly associated with COVID-19 infection, ventilation, and death.

CONCLUSION

Together, our findings suggest the shared genetics and causal association between AD and plasma ACE2 levels, which may partially explain the link between AD and COVID-19.

摘要

背景

阿尔茨海默病(AD)是感染 COVID-19、住院和死亡的最高风险。然而,AD 与 COVID-19 结局之间的联系在很大程度上仍不清楚。ACE2 是 SARS-CoV-2 的进入受体。循环 ACE2 是死亡的新型生物标志物,与 COVID-19 结局相关。

方法

在这里,我们使用大规模全基因组关联研究、基因表达、表达数量性状位点和高通量血浆蛋白质组学分析数据集,探讨了 AD 和血浆 ACE2 水平之间的共同遗传和因果关系。

结果

我们发现循环 ACE2 遗传增加与 AD 风险增加之间存在显著的因果关系。跨性状关联分析确定了 19 个共同的遗传变异,其中三个位于 6p21.32 染色体上的变异 rs3104412、rs2395166 和 rs3135344 与 COVID-19 感染、住院和严重程度相关。我们将 19 个变异映射到 117 个基因,这些基因在肺、脾和小肠中显著上调,在脑组织中下调,并参与免疫系统、免疫性疾病和传染病途径。与 LST1、AGER、TNXB 和 APOC1 对应的血浆蛋白主要与 COVID-19 感染、通气和死亡相关。

结论

总之,我们的研究结果表明 AD 和血浆 ACE2 水平之间存在共同的遗传和因果关系,这可能部分解释了 AD 和 COVID-19 之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/e1ba4634c527/CNS-30-e14873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/cd86a48be737/CNS-30-e14873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/b47737d45bf9/CNS-30-e14873-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/62d351698e3a/CNS-30-e14873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/0888892162db/CNS-30-e14873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/e1ba4634c527/CNS-30-e14873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/cd86a48be737/CNS-30-e14873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/b47737d45bf9/CNS-30-e14873-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/62d351698e3a/CNS-30-e14873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/0888892162db/CNS-30-e14873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5098/11273102/e1ba4634c527/CNS-30-e14873-g001.jpg

相似文献

1
Shared genetics and causal association between plasma levels of SARS-CoV-2 entry receptor ACE2 and Alzheimer's disease.阿尔茨海默病与 SARS-CoV-2 进入受体 ACE2 血浆水平的共享遗传和因果关联。
CNS Neurosci Ther. 2024 Jul;30(7):e14873. doi: 10.1111/cns.14873.
2
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入受体血管紧张素转换酶2(ACE2)在人脑中的表达及其与阿尔茨海默病和2019冠状病毒病(COVID-19)的关联
Mol Psychiatry. 2025 Apr 6. doi: 10.1038/s41380-025-03006-z.
3
Proteome-wide association studies using summary pQTL data of brain, CSF, and plasma identify 30 risk genes of Alzheimer's disease dementia.利用大脑、脑脊液和血浆的汇总蛋白质定量性状位点数据进行的全蛋白质组关联研究确定了30个阿尔茨海默病痴呆的风险基因。
Alzheimers Res Ther. 2025 Jun 18;17(1):135. doi: 10.1186/s13195-025-01774-y.
4
Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer's disease.用于识别阿尔茨海默病中细胞类型特异性和整体水平可成药靶点的多组学分析。
J Transl Med. 2025 Jul 13;23(1):788. doi: 10.1186/s12967-025-06739-1.
5
Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data.通过整合全面的孟德尔随机化和蛋白质组学数据鉴定阿尔茨海默病的生物标志物
J Transl Med. 2025 Mar 6;23(1):278. doi: 10.1186/s12967-025-06317-5.
6
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.小鼠血管紧张素转换酶2(ACE2)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染易感性的决定因素。
J Virol. 2025 Jun 17;99(6):e0054325. doi: 10.1128/jvi.00543-25. Epub 2025 May 12.
7
The Role of ACE2 Receptor and Its Polymorphisms in COVID-19 Infection and Severity and Its Association with Lipid Profile, Thrombin, and D-Dimer Levels in Iraqi Patients: A Cross-Sectional Study.ACE2受体及其多态性在伊拉克患者COVID-19感染、严重程度中的作用及其与血脂谱、凝血酶和D-二聚体水平的关联:一项横断面研究
Biochem Genet. 2024 Jul 31. doi: 10.1007/s10528-024-10890-7.
8
Multiomics analyses of the complex interplay between genetic variants, DNA methylation, and gene expression in COVID-19.新冠病毒中基因变异、DNA甲基化和基因表达之间复杂相互作用的多组学分析。
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H412-H422. doi: 10.1152/ajpheart.00206.2025. Epub 2025 Jul 1.
9
Context-specific eQTLs provide deeper insight into causal genes underlying shared genetic architecture of COVID-19 and idiopathic pulmonary fibrosis.特定背景下的eQTL为深入了解新冠病毒肺炎和特发性肺纤维化共同遗传结构背后的因果基因提供了线索。
HGG Adv. 2025 Apr 10;6(2):100410. doi: 10.1016/j.xhgg.2025.100410. Epub 2025 Jan 27.
10
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式,并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.

引用本文的文献

1
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入受体血管紧张素转换酶2(ACE2)在人脑中的表达及其与阿尔茨海默病和2019冠状病毒病(COVID-19)的关联
Mol Psychiatry. 2025 Apr 6. doi: 10.1038/s41380-025-03006-z.

本文引用的文献

1
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways.新型冠状病毒感染与严重程度的血浆蛋白质组学揭示了对阿尔茨海默病和冠心病通路的影响。
iScience. 2023 Apr 21;26(4):106408. doi: 10.1016/j.isci.2023.106408. Epub 2023 Mar 14.
2
High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone.可溶性 RAGE 水平升高与接受地塞米松治疗的 COVID-19 患者的死亡率增加相关。
Respir Res. 2022 Nov 5;23(1):303. doi: 10.1186/s12931-022-02220-5.
3
Association of COVID-19 with New-Onset Alzheimer's Disease.
COVID-19 与新发阿尔茨海默病的关联。
J Alzheimers Dis. 2022;89(2):411-414. doi: 10.3233/JAD-220717.
4
Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia.新型冠状病毒肺炎、甲型/乙型流感和细菌性肺炎后神经系统疾病的发生率
Front Neurol. 2022 Jun 23;13:904796. doi: 10.3389/fneur.2022.904796. eCollection 2022.
5
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease.帕金森病中的血管紧张素1型受体和血管紧张素转换酶2自身抗体。
NPJ Parkinsons Dis. 2022 Jun 14;8(1):76. doi: 10.1038/s41531-022-00340-9.
6
The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19.COVID-19 住院高血压患者的降压药物与死亡率的临床和生物信息学分析。
J Med Virol. 2022 Oct;94(10):4727-4734. doi: 10.1002/jmv.27914. Epub 2022 Jun 16.
7
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.支持人细胞膜结合型血管紧张素转换酶2(ACE2)的必要性以及反对可溶性ACE2对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染性作用的证据。
Cell. 2022 May 26;185(11):1837-1839. doi: 10.1016/j.cell.2022.05.004.
8
Genetic Landscape of the ACE2 Coronavirus Receptor.ACE2 冠状病毒受体的遗传景观。
Circulation. 2022 May 3;145(18):1398-1411. doi: 10.1161/CIRCULATIONAHA.121.057888. Epub 2022 Apr 7.
9
Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.COVID-19 感染在阿尔茨海默病或轻度认知障碍患者中的临床结局。
Alzheimers Dement. 2022 May;18(5):911-923. doi: 10.1002/alz.12665. Epub 2022 Apr 4.
10
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease.全基因组分析提供了遗传证据,表明 ACE2 影响 COVID-19 风险,并产生与严重疾病相关的风险评分。
Nat Genet. 2022 Apr;54(4):382-392. doi: 10.1038/s41588-021-01006-7. Epub 2022 Mar 3.